ISSN 2097-5724 CN 61-1535/R 主管·主办:陕西省疾病预防控制中心
疾病预防与控制 Disease Prevention and Control 医学学术期刊 双月刊
2026-03-044 检验与方法 2026, 2(03): 173-176

临床病理技术在胸腔积液细胞块中的应用价值分析

浙江中医药大学 2.浙江省肿瘤医院

33下载次数 0被引频次 26阅读次数 8参考文献
知网阅读全文
摘要

目的 本文主要针对临床病理技术在胸腔积液细胞块中的应用价值进行探究和分析。方法 回顾分析我院2023年12月份到2024年12月份期间确诊并且收治的100例胸腔积液患者作为研究对象,对其分别采取常规的细胞涂片法和细胞块免疫组化法进行对应的诊断,针对两种诊断方法所取得的检测结果进行比较、分析,并且形成书面记录。结果 针对我院临床确诊并且收治的100例胸腔积液患者采取不同临床病理技术进行诊断的情况下,细胞块免疫组化法检测阳性率达到了100%,明显高于细胞涂片的89.00%,两种病理诊断技术的检测结果组间差异显著,存在统计学意义(P<0.05)。结论 本研究发现,临床病理技术在胸腔积液细胞块中的应用价值显著,值得借鉴和全面推广。

Abstract

Objective This study investigates the clinical value of pathological techniques in diagnosing cellular masses in pleural effusion. Methods A retrospective analysis was conducted on 100 confirmed pleural effusion patients admitted to our hospital between December 2023 and December 2024. Both conventional cytology smear and cellular mass immunohistochemistry were employed for diagnosis. Comparative analysis of test results was performed with detailed documentation. Results Among the 100 patients diagnosed and treated at our hospital, cellular mass immunohistochemistry detection technology. Clinical testing demonstrated a 100% positive detection rate, significantly higher than the 89.00% rate of cytology smear. Statistical analysis revealed significant differences between the two diagnostic methods(P<0.05). Conclusion This study found that the application of clinical pathological techniques in pleural effusion cell blocks has significant positive value and is worthy of reference and comprehensive promotion.

引用本文

按标准格式复制,或导出到文献管理软件
[1]徐鑫宇.临床病理技术在胸腔积液细胞块中的应用价值分析[J].疾病预防与控制,2026,2(03):173-176.